← All organizations
Highest phase reached
Phase 3
First clinical trial
Jan 1, 2004Last known activity
Jun 30, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (5 distinct, 5 trials)
Phase 3 (4 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Indications
Recent trials (5)
- NCT06723392CollaboratorPhase 1Jun 30, 2025
- NCT06855108CollaboratorPhase 3Jun 30, 2025
- NCT05590260CollaboratorPhase 3Jan 1, 2023
- NCT03871491CollaboratorPhase 3Aug 1, 2019
- NCT00513396Overall official - principal investigatorPhase 2/Phase 3Jan 1, 2004
Details
- Last known activity
- Jun 30, 2025